论文部分内容阅读
CEA测定的临床意义有:1.恶性肿瘤的辅助诊断;2.癌症患者的进展程度及其予后的判断,治疗效果及转移、复发等病情观察的指标;原发性肝癌与转移性肝癌的鉴别等。血中CEA的定量测定,自1969年由Thomson等研究成功RIA法以来,又相继有Hansen等的Z-gel法(1971年)、Egan等的双抗体法(1972年)、Mc Pherson等的固相法(1973年),平井等的Sandwi-ch法(1976年)等报告。本文作者报告试用CEA·
The clinical significance of CEA measurement includes: 1. The auxiliary diagnosis of malignant tumors; 2. The progress of cancer patients and their subsequent judgment; The therapeutic effect and the indicators of the observation of metastasis and recurrence; primary liver cancer and metastatic liver cancer Identification and so on. Quantitative determination of CEA in blood has been studied since Thomson et al.’s successful RIA method in 1969, followed by Hansen et al’s Z-gel method (1971), Egan et al’s double antibody method (1972), and McPherson et al. The phase method (1973), Sandi et al.’s Sandwi-ch method (1976) and other reports. The author of this article reports a trial of CEA.